Focus:
News
-
2 June 2020
Regeneron and Intellia to develop new haemophilia therapies
Regeneron Pharmaceuticals has expanded its ongoing partnership with Intellia Therapeutics for the development of therapies for haemophilia A and B.
-
2 June 2020
Emergent gets $628m Covid-19 vaccine manufacturing contract
Emergent BioSolutions has secured a $628m contract from the US Biomedical Advanced Research and Development Authority (BARDA) for domestic manufacturing of Covid-19 vaccine candidates.
-
1 June 2020
AstraZeneca’s heart disease drug Brilinta gets FDA approval
AstraZeneca has received approval from the US Food and Drug Administration (FDA) for Brilinta (ticagrelor) to decrease the risk of a first heart attack or stroke in high-risk patients suffering...
-
1 June 2020
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19 antibody treatment, which led to a 100-fold decrease in the viral load of SARS-CoV-2.
-
1 June 2020
Russia grants temporary approval for Avifavir to treat Covid-19
The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and the ChemRar Group.
-
29 May 2020
Chimeron Bio and NCBID to develop Covid-19 vaccine
RNA therapeutics firm Chimeron Bio has collaborated with George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID) to develop a Covid-19 vaccine candidate.
-
29 May 2020
Novartis’ AveXis agrees to manufacture US researcher Covid-19 vaccine
Novartis unit AveXis has entered into a manufacturing agreement with researchers at Massachusetts Eye and Ear and Massachusetts General Hospital in the US to produce a genetic vaccine against Covid-19,...
-
29 May 2020
GSK plans to produce one billion pandemic vaccine adjuvant doses
GlaxoSmithKline (GSK) is set to produce one billion doses of its pandemic vaccine adjuvant system next year to support adjuvanted Covid-19 vaccine candidates development.
-
28 May 2020
India COVID-19 coronavirus by city and state
India has recorded 158,333 confirmed cases, 4,531 deaths, 67,692 cured cases, according to the latest update released by the Union Ministry for Health and Family Welfare on Thursday evening.
-
28 May 2020
Gilead and Arcus Biosciences partner to develop cancer drugs
Gilead Sciences has partnered with Arcus Biosciences to jointly develop and commercialise current and future cancer therapeutic candidates in the latter’s pipeline.
Close
Close
Close
Go Top